The mechanism for this lack of response may be related to fewer CD8 + T cells present in liver metastases and also decreased CD8 + T cell in tumor-infiltrating lymphocytes in non-liver sites in melanoma patients having liver metastases.28 The patients who had a pulmonary site chosen for SBRT had the highest proportion of response. This evidence concerns the gene CD8A and neoplasm.